Page 8 - Meredith Kaya News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apellis Pharmaceuticals Reports Third Quarter 2023 Financial Results

Generated total revenues of $110.4 million in the third quarter, including $75.3 million for SYFOVRE® and $23.9 million for EMPAVELI® SYFOVRE showed continued strong demand with growth.

San franciscoUnited statesUnited kingdomCedric francoisLissa pavlukMeredith kayaAmerican society of nephrologyRetina society annual scientific meetingApellis pharmaceuticals incAdvisory committee on immunization practicesEuropean medicines agencyEuropean unionAmerican academy of ophthalmology annual meeting onExchange commissionKidney weekAmerican society

Apellis Pharmaceuticals to Host Conference Call on November

WALTHAM, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference.

Meredith kayaApellis pharmaceuticals incNasdaq aplsApellis pharmaceuticals

The Lancet Publishes 24-Month Results from Phase 3 Studies of SYFOVRE® (pegcetacoplan injection) for Geographic Atrophy (GA)

SYFOVRE demonstrated clinically meaningful reductions in GA lesion growth in as few as six doses per yearOnly treatment approved for use beyond 12.

United kingdomUnited statesJeffrey heierCharles wykoffLissa pavlukCaroline baumalMeredith kayaResearch groupExchange commission onApellis pharmaceuticals incExchange commissionLancet glob healthRetina consultantsEleonora ladGeographic atrophySafety information

Apellis Pharmaceuticals (APLS) Announces Publication of 24-Month Results from Phase 3 Studies of SYFOVRE

Apellis Pharmaceuticals (APLS) Announces Publication of 24-Month Results from Phase 3 Studies of SYFOVRE
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJeffrey heierCaroline baumalLissa pavlukCharles wykoffMeredith kayaExchange commission onResearch groupLancet glob healthExchange commissionApellis pharmaceuticals incApellis pharmaceuticalsRetina consultantsEleonora ladGeographic atrophy

Apellis to Present Positive Phase 2 NOBLE Results of Pegcetacoplan in Post-Transplant Recurrence of Primary IC-MPGN and C3G at Kidney Week

Apellis to Present Positive Phase 2 NOBLE Results of Pegcetacoplan in Post-Transplant Recurrence of Primary IC-MPGN and C3G at Kidney Week
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew bombackMeredith kayaLissa pavlukCaroline baumalNational institute of healthExchange commissionColumbia university irving medical centerApellis pharmaceuticals incEuropean unionAmerican society of nephrologyNational kidney foundation websiteExchange commission onAmerican societyKidney week annualColumbia university irving medical